Navigation Links
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
Date:2/26/2013

s of CRP are predictive of severity of disease."

The Phase 2 study is a randomized, placebo-controlled, multiple-dose study evaluating the safety and efficacy of ISIS-CRPRx as a single agent in approximately 20 patients with AF who have pacemakers. The study is designed to evaluate the effects of ISIS-CRPRx on the frequency and duration of AF episodes. In addition to studying ISIS-CRPRx in AF, Isis is also currently evaluating ISIS-CRPRx in a Phase 2 study in patients with rheumatoid arthritis (RA), where CRP is chronically elevated. Top-line data from the Phase 2 RA study is planned for the middle of this year.

"ISIS-CRPRx is the first drug to test the hypothesis that lowering CRP levels could produce therapeutic benefit to patients. Although we are currently only evaluating ISIS-CRPRx in patients with rheumatoid arthritis and AF, if we are successful in demonstrating a significant benefit to lowering CRP in one or both of these diseases, there is a significant potential for ISIS-CRPRx to have broad application in numerous diseases with large commercial opportunity," concluded Lynne Parshall , chief operating officer at Isis.

ABOUT ISIS-CRPRx
ISIS-CRPRx­ is an antisense drug that is designed to inhibit the production of C-reactive protein (CRP).  For many years, CRP has been used as a clinical biomarker of diseases with an inflammatory component, such as cardiovascular disease, Crohn's disease, RA and end-stage renal disease.  Elevated levels of CRP have been linked to coronary artery disease and a growing body of evidence from clinical trials implicated CRP in cardiovascular disease progression.  Although CRP's active participation in these diseases remains to be determined, several lines of evidence support a causal role of CRP in disease, suggesting that it may be therapeutic
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
2. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
5. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
6. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
7. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
8. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
10. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
11. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Every day, their baby stopped breathing, his collapsed ... April and Bryan Gionfriddo watched helplessly, ... "Quite a few doctors said he had a good ... April Gionfriddo , about her now 20-month-old son, Kaiba. ... we would take it and run with it." ...
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Mich., Feb. 16, 2012  Waltonen Engineering, Inc., a ... announce that it has been awarded a U.S. ... Services (PES) Contract. "Waltonen currently ... Tank Automotive Research Development Engineering Center (TARDEC), Tank ...
... likelihood that Medicare beneficiaries are not receiving necessary medical ... urging Congress to adopt the Market Pricing Program ... home medical equipment and services, or durable medical equipment ... and Medicaid Services (CMS), which implemented the bidding program ...
Cached Medicine Technology:American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 2American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 3American Association for Homecare Calls for Market-Based Alternative to Medicare's Bidding Program; Cites Lack of Access for Beneficiaries 4
(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... dedicated to protecting the rights of victims injured by ... that Senior Litigation Counsel Matthew J. McCauley has been ... entitled In Re: Mirena IUD Products Liability Litigation (Case ... states that Co-Lead and Liaison Counsel are to submit ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 EnvirOasis, ... the contractor and ESCO market is pleased to announce ... Consortium (DLC) Listed LED products. EnvirOasis has been ... fixtures and retrofit kits and has recently brought ... LED (Light Emitting Diode) is energy efficient lighting ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Teen birth rates in the ... to a new government report. Overall, the rate of ... one half from 1991 to 2011 -- from about 62 ... 1,000. From 2007 to 2011, the most recent time ... 31. During that time, rates fell at least 30 ...
(Date:5/23/2013)... (HealthDay News) -- A shortage of a critical tuberculosis ... the United States to contain the spread of the ... drug, isoniazid (INH), was first used in 1951 and ... core of any first-line treatment for tuberculosis (TB). Patients ... according to the U.S. Centers for Disease Control and ...
Breaking Medicine News(10 mins):Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2
... good job of aggressively treating the early stages of ... diagnosis. The study involved 467 hospitals spread across 12 ... that patients may be treated less aggressively when they ... able to confirm the diagnosis,” said Chadwick Miller, M.D., ...
... Heart failure patients with untreated sleep apnea are more likely to ... ,The study followed 164 patients with heart failure for ... apnea (OSA) had double the death rate of those patients who ... OSA, the death rate was 24% in contrast to 12% for ...
... in the fight against obesity has started delivering results in ... pilot program was started in one of the middle schools ... eating habits among school children. ,Today nearly ... this three year old program called ‘Healthy School.’ ...
... that smoking and binge drinking among teenage girls have ... the health risks seem less important than those of ... young people correctly see cigarettes and alcohol as a ... to reflect that, Ofsted opined. Pupils also felt let ...
... NHS services’, UK ‘s Health Minister Patricia Hewitt launched ... select their hospital and doctor, as well as access information on ... to put patients at the heart of the NHS and making ... a crucial part of that. “Patients will soon be able to ...
... welcomed the Government’s decision to officially recognise the Australian ... for rural GPs. ,“Rural GPs are the ... ,“Formal recognition for rural GPs who complete ... workforce in rural and regional areas.” ,The ...
Cached Medicine News:Health News:Doctors Treat Early Heart Attacks Before Labs Could Confirmation It 2Health News:Doctors Treat Early Heart Attacks Before Labs Could Confirmation It 3Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 3Health News:Campaign Against Obesity Taken to Schools in US 2Health News:Parents To Blame For Soaring Counts Of Binge-Drinkers And Smokers 2Health News:NHS Online- Promise Of ‘Choices’ To Patien 2